HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Volante Selected Research

Biomarkers (Surrogate Marker)

5/2023Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.
1/2023Histopathologic Features of Adrenal Cortical Carcinoma.
6/2022Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression.
3/2022Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
9/2021NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images.
5/2021Differential Expression Profiles of Cell-to-Matrix-Related Molecules in Adrenal Cortical Tumors: Diagnostic and Prognostic Implications.
3/2021Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
1/2021Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids.
7/2020Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe.
11/2019The Prognostic Role of CD8+ T Lymphocytes in Childhood Adrenocortical Carcinomas Compared to Ki-67, PD-1, PD-L1, and the Weiss Score.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Volante Research Topics

Disease

111Neoplasms (Cancer)
12/2023 - 01/2000
32Carcinoma (Carcinomatosis)
12/2023 - 10/2002
24Adrenocortical Carcinoma
05/2021 - 12/2006
16Carcinoid Tumor (Carcinoid)
05/2024 - 12/2010
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 10/2006
9Adenocarcinoma
02/2021 - 06/2006
8Neoplasm Metastasis (Metastasis)
12/2023 - 10/2006
8Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2023 - 11/2007
8Adrenal Cortex Neoplasms (Adrenocortical Cancer)
12/2019 - 12/2008
7Lung Neoplasms (Lung Cancer)
12/2023 - 05/2009
7Neuroendocrine Carcinoma
09/2022 - 11/2009
7Thyroid Neoplasms (Thyroid Cancer)
12/2020 - 01/2000
5Disease Progression
12/2019 - 06/2008
5Prostatic Neoplasms (Prostate Cancer)
01/2019 - 06/2008
4Mesothelioma
08/2022 - 06/2014
4Adenoma (Adenomas)
05/2021 - 08/2005
4Necrosis
01/2021 - 12/2011
4Malignant Mesothelioma
01/2021 - 06/2014
3Infections
04/2024 - 10/2012
3Pheochromocytoma
11/2023 - 06/2015
3Cushing Syndrome
11/2023 - 04/2014
3Carcinogenesis
08/2021 - 01/2003
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 03/2007
3Adenocarcinoma of Lung
04/2020 - 06/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2019 - 10/2006
3Parathyroid Neoplasms (Parathyroid Neoplasm)
01/2013 - 08/2005
2Renal Cell Carcinoma (Grawitz Tumor)
12/2022 - 09/2021
2Papillary Carcinoma
01/2022 - 10/2002
2Papillary Thyroid Cancer
01/2022 - 04/2003
2Lymphatic Metastasis
01/2022 - 01/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 08/2009
2Adrenal Insufficiency (Adrenal Gland Hypofunction)
09/2021 - 10/2017
2Genetic Predisposition to Disease (Genetic Predisposition)
05/2021 - 08/2006
2Small Cell Carcinoma
09/2019 - 12/2010
2Paraganglioma (Paragangliomas)
01/2017 - 06/2015
2Adrenal Gland Neoplasms (Adrenal Cancer)
02/2015 - 01/2014
2Hypoxia (Hypoxemia)
08/2014 - 11/2005
2Starvation
07/2014 - 07/2009
2Breast Neoplasms (Breast Cancer)
01/2014 - 10/2010
2Inflammation (Inflammations)
08/2012 - 08/2010

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
11/2023 - 10/2002
21Biomarkers (Surrogate Marker)IBA
05/2023 - 03/2014
13Messenger RNA (mRNA)IBA
11/2023 - 03/2002
13Mitotane (Lysodren)FDA Link
01/2020 - 12/2008
9DNA (Deoxyribonucleic Acid)IBA
09/2023 - 09/2004
9Thymidylate SynthaseIBA
08/2022 - 10/2006
7MicroRNAs (MicroRNA)IBA
08/2022 - 08/2014
7Hormones (Hormone)IBA
09/2021 - 03/2002
7ParaffinIBA
05/2021 - 10/2002
7Galectin 3 (LGALS3)IBA
06/2008 - 10/2002
6AndrogensIBA
01/2019 - 06/2008
6ErbB Receptors (EGF Receptor)IBA
12/2017 - 03/2007
6GhrelinIBA
01/2013 - 03/2002
5Reticulin (Reticular Fiber)IBA
12/2023 - 12/2011
5RNA (Ribonucleic Acid)IBA
09/2023 - 06/2008
5Transcription Factors (Transcription Factor)IBA
12/2022 - 07/2013
5Tyrosine Kinase InhibitorsIBA
12/2018 - 09/2007
5Formaldehyde (Formol)FDA Link
03/2015 - 01/2003
4Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020 - 01/2003
4AntibodiesIBA
11/2019 - 06/2007
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2018 - 11/2007
4MucinsIBA
01/2017 - 09/2007
4Chromogranin AIBA
11/2010 - 08/2005
3Antiviral Agents (Antivirals)IBA
04/2024 - 10/2012
3Histones (Histone)IBA
03/2021 - 09/2014
3prolinedithiocarbamate (PDTC)IBA
12/2020 - 03/2010
3EnzymesIBA
01/2020 - 08/2006
3somatostatin receptor 2IBA
01/2020 - 01/2018
3Phosphotransferases (Kinase)IBA
12/2018 - 12/2013
3TOR Serine-Threonine KinasesIBA
06/2018 - 12/2010
3SteroidsIBA
10/2017 - 10/2013
3Caveolin 1IBA
12/2016 - 07/2009
3Coloring Agents (Dyes)IBA
09/2013 - 06/2007
3Fluorouracil (Carac)FDA LinkGeneric
06/2010 - 02/2008
2Adrenocorticotropic Hormone (ACTH)FDA Link
11/2023 - 11/2019
2Temozolomide (Temodar)FDA LinkGeneric
01/2023 - 12/2019
2AsbestosIBA
05/2021 - 09/2019
2Cisplatin (Platino)FDA LinkGeneric
04/2021 - 11/2009
2xylometazoline (stas)IBA
01/2021 - 09/2019
2LipidsIBA
01/2021 - 01/2013
2Peptide Receptors (Peptide Receptor)IBA
01/2020 - 01/2003
2MTOR InhibitorsIBA
06/2018 - 12/2010
2Mechanistic Target of Rapamycin Complex 1IBA
06/2018 - 01/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 05/2015
2Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2012
2Monoclonal AntibodiesIBA
01/2018 - 04/2003
2Mitochondrial DNA (mtDNA)IBA
11/2017 - 12/2011
2Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2017 - 01/2003
2NucleotidesIBA
01/2017 - 03/2013
2Matrix Metalloproteinases (MMPs)IBA
12/2016 - 12/2006
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2015 - 06/2012
2Steroidogenic Factor 1IBA
08/2014 - 05/2013
2Octreotide (Sandostatin)FDA LinkGeneric
03/2014 - 11/2009
2Capecitabine (Xeloda)FDA Link
03/2014 - 06/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014 - 10/2010
2GemcitabineFDA Link
01/2014 - 06/2010
2Cytotoxins (Cytolysins)IBA
01/2014 - 05/2009
2Peptides (Polypeptides)IBA
07/2012 - 01/2003

Therapy/Procedure

26Therapeutics
05/2024 - 01/2003
12Drug Therapy (Chemotherapy)
12/2023 - 02/2009